Table of Contents
Chapter 1. Global Meningococcal Vaccines Market Executive Summary
1.1. Global Meningococcal Vaccines Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Vaccine Serotype
1.3.2. By Vaccine Type
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Meningococcal Vaccines Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Meningococcal Vaccines Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption in Immunization Programs
3.1.2. Surge in Meningococcal Outbreaks
3.2. Market Challenges
3.2.1. Stringent Government Regulations
3.2.2. Product Recalls Due to Contamination
3.3. Market Opportunities
3.3.1. Increase in R&D Activities
3.3.2. Rising Healthcare Expenditure
Chapter 4. Global Meningococcal Vaccines Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Meningococcal Vaccines Market Size & Forecasts by Vaccine Serotype 2022-2032
5.1. Segment Dashboard
5.2. Global Meningococcal Vaccines Market: Vaccine Serotype Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. MenACWY
5.2.2. MenB & Manic
5.2.3. MenC
5.2.4. MenA
5.2.5. MenAC
Chapter 6. Global Meningococcal Vaccines Market Size & Forecasts by Vaccine Type 2022-2032
6.1. Segment Dashboard
6.2. Global Meningococcal Vaccines Market: Vaccine Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Conjugate
6.2.2. Polysaccharide
6.2.3. Subcapsular
Chapter 7. Global Meningococcal Vaccines Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Meningococcal Vaccines Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Pediatric
7.2.2. Adult
7.2.3. Travelers
Chapter 8. Global Meningococcal Vaccines Market Size & Forecasts by Region 2022-2032
8.1. North America Meningococcal Vaccines Market
8.1.1. U.S. Meningococcal Vaccines Market
8.1.1.1. Vaccine Serotype breakdown size & forecasts, 2022-2032
8.1.1.2. Vaccine Type breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Meningococcal Vaccines Market
8.2. Europe Meningococcal Vaccines Market
8.2.1. U.K. Meningococcal Vaccines Market
8.2.2. Germany Meningococcal Vaccines Market
8.2.3. France Meningococcal Vaccines Market
8.2.4. Spain Meningococcal Vaccines Market
8.2.5. Italy Meningococcal Vaccines Market
8.2.6. Rest of Europe Meningococcal Vaccines Market
8.3. Asia-Pacific Meningococcal Vaccines Market
8.3.1. China Meningococcal Vaccines Market
8.3.2. India Meningococcal Vaccines Market
8.3.3. Japan Meningococcal Vaccines Market
8.3.4. Australia Meningococcal Vaccines Market
8.3.5. South Korea Meningococcal Vaccines Market
8.3.6. Rest of Asia Pacific Meningococcal Vaccines Market
8.4. Latin America Meningococcal Vaccines Market
8.4.1. Brazil Meningococcal Vaccines Market
8.4.2. Mexico Meningococcal Vaccines Market
8.4.3. Rest of Latin America Meningococcal Vaccines Market
8.5. Middle East & Africa Meningococcal Vaccines Market
8.5.1. Saudi Arabia Meningococcal Vaccines Market
8.5.2. South Africa Meningococcal Vaccines Market
8.5.3. Rest of Middle East & Africa Meningococcal Vaccines Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GlaxoSmithKline plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Pfizer Inc.
9.3.3. Sanofi Pasteur
9.3.4. Merck & Co., Inc.
9.3.5. Novartis AG
9.3.6. CSL Limited
9.3.7. Johnson & Johnson
9.3.8. Bharat Biotech International Limited
9.3.9. Serum Institute of India Pvt. Ltd.
9.3.10. Sinovac Biotech Ltd.
9.3.11. Biological E Limited
9.3.12. Chongqing Zhifei Biological Products Co., Ltd.
9.3.13. Beijing Tiantan Biological Products Co., Ltd.
9.3.14. Hualan Biological Engineering Inc.
9.3.15. Walvax Biotechnology Co., Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes